Inventor
SPILBURG CURTIS A
20 patents
⚠️ This page may combine multiple inventors who share the name “SPILBURG CURTIS A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LANGE III LOUIS G
4 patentsUS5063210ANov 5, 1991
Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
LANGE III LOUIS G54 citations95
US5017565AMay 21, 1991
Use of sulfated polysaccharides to inhibit pancreatic cholesterol esterase
LANGE III LOUIS G25 citations91
US5352601AOct 4, 1994
Method for recovering purified 52,000 dalton fraction of human pancreatic cholesterol esterase using deae-cellulose, hydroxyapatite and heparin-sepharose
LANGE III LOUIS G9 citations70
US5492822AFeb 20, 1996
Method for recovering purified 100,000 dalton molecular weight fraction of human pancreatic cholesterol esterase
LANGE III LOUIS G4 citations59
MONSANTO CO
4 patentsUS4720486AJan 19, 1988
Method of inhibiting vertebrate collagenase activity using peptide hydroxamic acid derivatives
MONSANTO CO69 citations95
US4687841AAug 18, 1987
Peptide hydroxamic acid derivatives
MONSANTO CO71 citations91
US4752578AJun 21, 1988
Collagenase inducing factor
MONSANTO CO9 citations73
US4243582AJan 6, 1981
Novel glycoproteins from bovine cartilage
MONSANTO CO19 citations71
(unassigned)
4 patentsUS5616570AApr 1, 1997
Use of non-absorbable synthetic sulfated polysaccharides to decrease cholesterol absorbtion
19 citations92
US5484777AJan 16, 1996
Pancreatic cholesterol esterase inhibitor
22 citations92
US5624836AApr 29, 1997
DNA encoding bovine pancreatic cholesterol esterase
6 citations70
US5792832AAug 11, 1998
Peptides from mammalian pancreatic cholesterol esterase
0 citations49
CV THERAPEUTICS INC
4 patentsUS5981299ANov 9, 1999
Mammalian pancreatic cholesterol esterase
CV THERAPEUTICS INC5 citations71
US7071174B1Jul 4, 2006
Method and composition for inhibiting cholesterol esterase
CV THERAPEUTICS INC2 citations62
US5521303AMay 28, 1996
Method of manufacturing non-absorbable synthetic sulfated polysaccharides
CV THERAPEUTICS INC4 citations62
US6632801B1Oct 14, 2003
Method and composition for inhibiting human cholesterol esterase
CV THERAPEUTICS INC1 citations52